(Q35129382)

6 August 2017

1 reference

title

Clinically important drug interactions with zopiclone, zolpidem and zaleplon (English)

1 reference

6 August 2017

Clinically Important Drug Interactions with Zopiclone, Zolpidem and Zaleplon (English)

1 reference

https://api.crossref.org/works/10.2165/00023210-200317070-00004

3 January 2024

3

David J Greenblatt

1 reference

6 August 2017

2

Lisa L von Moltke

1 reference

6 August 2017

1

Leah M Hesse

1 reference

6 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12751920

3 January 2024

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

17

1 reference

6 August 2017

issue

7

1 reference

6 August 2017

page(s)

513-532

1 reference

The effect of co-administration of zolpidem with fluoxetine: pharmacokinetics and pharmacodynamics

6 August 2017

cites work

1 reference

12 December 2020

Effects of age and other drugs on benzodiazepine kinetics

1 reference

12 December 2020

Comparative effects of rifampin and/or probenecid on the pharmacokinetics of temazepam and nitrazepam

1 reference

12 December 2020

Effect of antacid and H2 receptor antagonists on the intestinal absorption of folic acid

1 reference

12 December 2020

Concentrations and effects of zopiclone are greatly reduced by rifampicin

1 reference

12 December 2020

Triazolam is ineffective in patients taking rifampin

1 reference

12 December 2020

Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.

1 reference

12 December 2020

Cimetidine and ranitidine increase midazolam bioavailability.

1 reference

12 December 2020

Pharmacokinetics and metabolism of zopiclone

1 reference

12 December 2020

Effect of pretreatment with ranitidine on the hypnotic action of single doses of midazolam, temazepam and zopiclone. A clinical study.

1 reference

12 December 2020

Mirtazapine may be useful in treating nausea and insomnia of cancer chemotherapy

1 reference

12 December 2020

Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia

1 reference

12 December 2020

A potentially hazardous interaction between erythromycin and midazolam.

1 reference

12 December 2020

The acute effects of zolpidem, administered alone and with alcohol, on cognitive and psychomotor function.

1 reference

12 December 2020

The effect of antipyrine and rifampin on the metabolism of diazepam.

1 reference

12 December 2020

Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole.

1 reference

12 December 2020

Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia

1 reference

12 December 2020

Sleep in psychiatric disorders

1 reference

12 December 2020

Depression, circadian rhythms and trimipramine

1 reference

12 December 2020

Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders

1 reference

12 December 2020

Midazolam 12 mg is moderately counteracted by 250 mg caffeine in man.

1 reference

12 December 2020

Inhibition of Theophylline Clearance by Cimetidine but not Ranitidine

1 reference

12 December 2020

Differential effect of cimetidine on drug oxidation (antipyrine and diazepam) vs. conjugation (acetaminophen and lorazepam): prevention of acetaminophen toxicity by cimetidine.

1 reference

12 December 2020

Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update

1 reference

12 December 2020

Lack of interaction between zolpidem and H2 antagonists, cimetidine and ranitidine

1 reference

12 December 2020

Oxazepam pharmacokinetics in patients with epilepsy treated long-term with phenytoin alone or in combination with phenobarbitone

1 reference

12 December 2020

Differential impairment of triazolam and zolpidem clearance by ritonavir

1 reference

12 December 2020

Minimal rebound insomnia after treatment with 10-mg zolpidem

1 reference

12 December 2020

Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism

1 reference

12 December 2020

Interactions and comparative effects of zopiclone, diazepam and lorazepam on psychomotor performance and on elimination pharmacokinetics in healthy volunteers

1 reference

12 December 2020

Pharmacokinetic and clinical parameters of zopiclone and trimipramine when administered simultaneously to volunteers

1 reference

12 December 2020

Metabolism of anxiolytics and hypnotics: benzodiazepines, buspirone, zoplicone, and zolpidem

1 reference

12 December 2020

Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential

1 reference

12 December 2020

St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor

1 reference

12 December 2020

Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays

1 reference

12 December 2020

Bromazepam pharmacokinetics: influence of age, gender, oral contraceptives, cimetidine, and propranolol

1 reference

12 December 2020

Erythromycin: a motilin agonist and gastrointestinal prokinetic agent

1 reference

12 December 2020

Critical factors for pharmacokinetics of zopiclone in the elderly and in patients with liver and renal insufficiency

1 reference

12 December 2020

The effects of low and moderate doses of alcohol on the pharmacokinetic parameters of zopiclone

1 reference

12 December 2020

Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zolpidem

1 reference

12 December 2020

Lack of interaction of erythromycin with temazepam

1 reference

12 December 2020

Review article: drug interactions with agents used to treat acid-related diseases

1 reference

12 December 2020

Oxidative metabolism of zolpidem by human liver cytochrome P450S

1 reference

12 December 2020

Triazolam Kinetics: Interaction with Cimetidine, Propranolol, and the Combination

1 reference

12 December 2020

Caffeine and theophylline counteract diazepam effects in man

1 reference

12 December 2020

A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder

1 reference

12 December 2020

Interaction between midazolam and clarithromycin: comparison with azithromycin.

1 reference

12 December 2020

Management of insomnia

1 reference

12 December 2020

Tricyclic antidepressants in the treatment of insomnia

1 reference

12 December 2020

Limitations of the benzodiazepine receptor nomenclature: a proposal for a pharmacological classification as omega receptor subtypes

1 reference

12 December 2020

Influence of cimetidine on the pharmacokinetics of desmethyldiazepam and oxazepam.

1 reference

12 December 2020

Cytochrome P-450 3A4 and 2C8 are involved in zopiclone metabolism.

1 reference

12 December 2020

Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole

1 reference

12 December 2020

Lack of effect of sertraline on the pharmacokinetics of alprazolam

1 reference

12 December 2020

Interaction of cimetidine with the triazolobenzodiazepines alprazolam and triazolam

1 reference

12 December 2020

Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences

1 reference

12 December 2020

Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors

1 reference

12 December 2020

The importance of new antidepressants in the treatment of anxiety/depressive disorders

1 reference

12 December 2020

Concentrations and effects of oral midazolam are greatly reduced in patients treated with carbamazepine or phenytoin.

1 reference

12 December 2020

Human cytochromes and some newer antidepressants: kinetics, metabolism, and drug interactions.

1 reference

12 December 2020

Zopiclone. An update of its pharmacology, clinical efficacy and tolerability in the treatment of insomnia

1 reference

12 December 2020

Elevation of steady-state diazepam levels by cimetidine

1 reference

12 December 2020

Side effects from increased doses of carbamazepine on neuropsychological and posturographic parameters of humans

1 reference

12 December 2020

Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole

1 reference

12 December 2020

Reboxetine: a selective norepinephrine reuptake inhibitor for the treatment of depression

1 reference

12 December 2020

Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications

1 reference

12 December 2020

Rifampin reduces plasma concentrations and effects of zolpidem.

1 reference

12 December 2020

Possible interactions between zolpidem, a new sleep inducer and chlorpromazine, a phenothiazine neuroleptic.

1 reference

12 December 2020

Prediction of in vivo interaction between triazolam and erythromycin based on in vitro studies using human liver microsomes and recombinant human CYP3A4

1 reference

12 December 2020

Quantitative RT-PCR Measurement of Human Cytochrome P-450s: Application to Drug Induction Studies

1 reference

12 December 2020

Drug interactions with antisecretory agents

1 reference

12 December 2020

An interaction study with cimetidine and the new angiotensin II antagonist valsartan

1 reference

12 December 2020

The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity

1 reference

12 December 2020

Minimal interaction between fluoxetine and multiple-dose zolpidem in healthy women.

1 reference

12 December 2020

Metabolism of Zaleplon by human hepatic microsomal cytochrome P450 isoforms

1 reference

12 December 2020

Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic

1 reference

12 December 2020

Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers.

1 reference

12 December 2020

Central nervous system side effects associated with zolpidem treatment

1 reference

12 December 2020

Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations

1 reference

12 December 2020

Selectivity for omega-receptor subtypes as a strategy for the development of anxiolytic drugs

1 reference

12 December 2020

A pharmacokinetic evaluation of the combined administration of triazolam and fluoxetine

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition

1 reference

12 December 2020

Drug utilization review of concomitant use of specific serotonin reuptake inhibitors or clomipramine with antianxiety/sleep medications

1 reference

12 December 2020

Zaleplon: a review of its use in the treatment of insomnia

1 reference

12 December 2020

Coadministration of short-term zolpidem with sertraline in healthy women

1 reference

12 December 2020

Sertraline does not inhibit cytochrome P450 3A-mediated drug metabolism in vivo

1 reference

12 December 2020

Characterization of the interaction of zopiclone with gamma-aminobutyric acid type A receptors.

1 reference

12 December 2020

Zolpidem 10 mg given at daytime is not antagonized by 300 mg caffeine in man.

1 reference

12 December 2020

Noninteraction of temazepam and cimetidine

1 reference

12 December 2020

A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamine.

1 reference

12 December 2020

A pharmacokinetic drug interaction between erythromycin and triazolam

1 reference

12 December 2020

Effect of zaleplon on digoxin pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Differential time course of cytochrome P450 2D6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteers

1 reference

12 December 2020

Effects of zaleplon or triazolam with or without ethanol on human performance.

1 reference

12 December 2020

Treatment of sleep disturbances in depressed patients

1 reference

12 December 2020

Absence of an interaction between ibuprofen and zaleplon.

1 reference

12 December 2020

Actions of zopiclone and carbamazepine, alone and in combination, on human skilled performance in laboratory and clinical tests

1 reference

12 December 2020

Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists

1 reference

12 December 2020

Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences

1 reference

12 December 2020

Actions and interactions of hypnotics on human performance: single doses of zopiclone, triazolam and alcohol

1 reference

12 December 2020

Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: role of CYP2B6, 2C19 and the 3A subfamily.

1 reference

12 December 2020

Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole

1 reference

12 December 2020

1 reference

12 December 2020

Use of complementary medicine by adult patients participating in HIV/AIDS clinical trials.

1 reference

12 December 2020

Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zopiclone

1 reference

12 December 2020

Drug-alcohol interactions on psychomotor skills: zopiclone and flunitrazepam.

1 reference

12 December 2020

The effect of cyclopyrrolones on GABAA receptor function is different from that of benzodiazepines

1 reference

12 December 2020

Caffeine moderately antagonizes the effects of triazolam and zopiclone on the psychomotor performance of healthy subjects

1 reference

12 December 2020

The effect of erythromycin on the pharmacokinetics and pharmacodynamics of zopiclone

1 reference

12 December 2020

Flumazenil antagonizes the central effects of zolpidem, an imidazopyridine hypnotic

1 reference

12 December 2020

Diazepam interaction with antituberculosis drugs.

1 reference

12 December 2020

Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes

1 reference

12 December 2020

Rifampin drastically reduces plasma concentrations and effects of oral midazolam.

1 reference

12 December 2020

Pharmacokinetic drug interactions with rifampicin

1 reference

12 December 2020

Suriclone enhances the actions of chlorpromazine on human psychomotor performance but not on memory or plasma prolactin in healthy subjects.

1 reference

12 December 2020

Psychomotor effects of zaleplon and thioridazine coadministration

1 reference

12 December 2020

Interaction of H2-receptor antagonists and benzodiazepine sedation. A double-blind placebo-controlled investigation of the effects of cimetidine and ranitidine on recovery after intravenous midazolam.

1 reference

12 December 2020

Fluoxetine impairs clearance of alprazolam but not of clonazepam

1 reference

12 December 2020

Lack of effect of antimycotic itraconazole on the pharmacokinetics or pharmacodynamics of temazepam

1 reference

12 December 2020

Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors

1 reference

12 December 2020

16

26

617

Allard

1998

1 reference

https://api.crossref.org/works/10.2165/00023210-200317070-00004

3 January 2024

37

23

1253

Pichard

1995

1 reference

https://api.crossref.org/works/10.2165/00023210-200317070-00004

3 January 2024

41

21

1125

Fernandez

1993

1 reference

https://api.crossref.org/works/10.2165/00023210-200317070-00004

3 January 2024

45

27

1068

Becquemont

1999

1 reference

https://api.crossref.org/works/10.2165/00023210-200317070-00004

International journal of clinical pharmacology, therapy, and toxicology

3 January 2024

53

28

387

Brockmeyer

1990

1 reference

https://api.crossref.org/works/10.2165/00023210-200317070-00004

3 January 2024

85

11

930

Grimsley

1992

1 reference

https://api.crossref.org/works/10.2165/00023210-200317070-00004

British journal of hospital medicine

3 January 2024

99

51

346

Cone

1994

1 reference

https://api.crossref.org/works/10.2165/00023210-200317070-00004

3 January 2024

100

61

337

Mattila

1983

1 reference

https://api.crossref.org/works/10.2165/00023210-200317070-00004

3 January 2024

Identifiers

1 reference

Dimensions Publication ID

6 August 2017

1042550241

0 references

1 reference